BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
505 results:

  • 1. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms.
    Gerami P; Chen A; Sharma N; Patel P; Hagstrom M; Kancherla P; Geraminejad T; Olivares S; Biswas A; Bosenberg M; Busam KJ; de La Fouchardière A; Duncan LM; Elder DE; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Mihic-Probst D; Parker DC; Scolyer RA; Shea CR; Zembowicz A; Yun SJ; Blokx WAM; Barnhill RL
    Am J Surg Pathol; 2024 May; 48(5):538-545. PubMed ID: 38525831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
    Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
    J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
    Phillips GS; Mengden-Koon S; Dhossche J; LeBoit PE; Goldstein AM; Lee I; Raffeld M; Papanicolau-Sengos A; Sargen MR; Chung J
    J Cutan Pathol; 2024 Mar; 51(3):198-204. PubMed ID: 38031352
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phytocompounds from essential oil of Mentha aquatica L. cv. Lime prevent vemurafenib-promoted skin carcinogenesis via inhibiting hras
    Chang CT; Chen YH; Shyur LF
    Phytomedicine; 2024 Jan; 122():155161. PubMed ID: 37939409
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Spitz tumor with RAF1 fusion: A report of 3 cases.
    Donati M; Nosek D; Olivares S; Lemahieu J; Loontiens S; Mansour B; Gerami P; Kazakov DV
    Ann Diagn Pathol; 2023 Dec; 67():152215. PubMed ID: 37856952
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Geraminejad T; Olivares S; Donati M; Nosek D; Waldenbäck P; Kazakov D; Sheffield BS; Tron VA; Gerami P
    Am J Surg Pathol; 2023 Dec; 47(12):1438-1448. PubMed ID: 37773074
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Spectrum of HPV-independent Penile Intraepithelial Neoplasia: A Proposal for Subclassification.
    Regauer S; Ermakov M; Kashofer K
    Am J Surg Pathol; 2023 Dec; 47(12):1449-1460. PubMed ID: 37768009
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic and phenotypic diversities of nevus spilus phenotypes: Case series and a proposed diagnostic algorithm.
    Zhang J; Xu Q; Deng D
    Clin Genet; 2023 Nov; 104(5):593-597. PubMed ID: 37501405
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Agminated presentation of fusion-driven melanocytic neoplasms.
    Fumero-Velázquez M; Hagstrom M; Dhillon S; Olivares S; Jennings LJ; Dittman D; Sukhanova M; Arva NC; Goldstein SD; Theos A; Pavlidakey P; Carr Z; Gerami P
    J Cutan Pathol; 2023 Oct; 50(10):913-921. PubMed ID: 37407520
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Schimmelpenning-Feuerstein-Mims syndrome induced by hras Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
    Wen S; Zeng J; Zhong L; Ye J; Lai X
    Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.
    Cornejo KM; Hutchinson L; O'Donnell P; Meng X; Tomaszewicz K; Shalin SC; Cassarino DS; Chan MP; Quinn TR; Googe PB; Nazarian RM
    Arch Pathol Lab Med; 2024 Feb; 148(2):215-222. PubMed ID: 37074845
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases.
    Mansour B; Vanecek T; Kastnerova L; Nosek D; Kazakov DV; Donati M
    Am J Dermatopathol; 2023 May; 45(5):306-310. PubMed ID: 36939120
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
    Kim YS; Park GS; Chung YJ; Lee JH
    J Dermatol; 2023 Aug; 50(8):1072-1075. PubMed ID: 36938660
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. hras-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
    Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
    Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis.
    Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF
    Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022
    [No Abstract]    [Full Text] [Related]  

  • 17. An update on genomic aberrations in Spitz naevi and tumours.
    Hagstrom M; Fumero-Velázquez M; Dhillon S; Olivares S; Gerami P
    Pathology; 2023 Mar; 55(2):196-205. PubMed ID: 36631338
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
    Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
    JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primary mucosal melanomas of the head and neck are characterised by overexpression of the DNA mutating enzyme APOBEC3B.
    Argyris PP; Naumann J; Jarvis MC; Wilkinson PE; Ho DP; Islam MN; Bhattacharyya I; Gopalakrishnan R; Li F; Koutlas IG; Giubellino A; Harris RS
    Histopathology; 2023 Mar; 82(4):608-621. PubMed ID: 36416305
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Next-generation Sequencing as a Potential Diagnostic Adjunct in Distinguishing Between Desmoplastic Melanocytic Neoplasms.
    Roth A; Boutko A; Lampley N; Dhillon S; Hagstrom M; Olivares S; Dittman D; Jennings L; Santana Dos Santos L; Busam K; Gerami P
    Am J Surg Pathol; 2023 Mar; 47(3):318-325. PubMed ID: 36383901
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.